Companies are having to making a choice: Include coverage for an in-demand class of drugs that come at a high cost, or lose employees who say want that benefit.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
At its given pace, colorectal cancer will seize the No. 1 spot as the top killer of Americans aged 20 to 49 within seven years. Cases of the deadly cancer – its warning signs not […]
When a Twitter follower praised Elon Musk’s new “awesome, fit, ripped and healthy” look, the billionaire entrepreneur replied that his secret was “fasting” and “Wegovy.” Given society’s obsession with celebrities and weight loss and Musk’s […]
EVANSTON, Ill., July 9, 2025 /PRNewswire/ — Cyclopure is pleased to announce that it has been selected by the Colorado Department of Public Health & Environment (CDPHE) to provide PFAS water testing services for private […]
Copyright © 2026 Biotech Networks
